All submissions should be written in
English
.
Please revise your paper based on the template below:
Authors submit full papers (4–6 pages) or abstracts adhering to the conference’s template via the online system. Papers must be original, unpublished, and not under review elsewhere.
Submissions undergo a pre-screening by the organizing committee to check for compliance with scope, formatting, and ethical standards. Papers that fail this stage are rejected without further review.
Papers are assigned to 2–3 expert reviewers from the technical program committee or external scholars with expertise in bioinformatics, biomedicine, or statistics.
Reviewers assess papers based on:
Originality: Novelty of methods, algorithms, or applications.
Technical Rigor: Soundness of methodology, data analysis, and statistical approaches.
Relevance: Alignment with the conference’s themesClarity: Quality of writing, logical flow, and presentation of results.
Significance: Potential impact on the field or practical implications.
Based on reviewer recommendations, the program committee (PC) chairs decide to:
Accept the paper as-is.
Request Revisions (minor or major) for resubmission.
Reject the paper if it fails to meet standards.
Reviewers provide constructive comments to help authors improve their work. Rejected papers receive detailed explanations for the decision.
Accepted papers are published in conference proceedings and at least one author must register and present the paper at the conference (either orally or as a poster). Virtual presentations may be allowed under specific circumstances.
Your submission must be original. AIBDCS 2026 only accepts original submissions. This means that your submission cannot have been published in another peer-reviewed venue or be under concurrent review at another peer-reviewed venue. Similarly, if you make multiple submissions to AIBDCS 2026 Papers, their contributions must be distinct & self-contained from each other. Authors should avoid using text generated by AI-tools (e.g., LLMs such as ChatGPT or similar). The use of AI-tools must be disclosed in the acknowledgements section of your submission.
